Number of smokers using NHS services to quit halves, report finds The number of smokers who quit smoking through the NHS Stop Smoking Service will halve in England in 2014–2015, according to a UCL report.…
US FDA approves drug that prolongs survival in rare paediatric cancer The US Food and Drug Administration has approved dinutuximab as part of first-line therapy for a rare childhood cancer, neuroblastoma. …
Goserelin protects against ovarian failure in women treated for breast cancer Research suggests that the gonadotropin-releasing hormone agonist goserelin can help protect against ovarian failure in women treated for breast cancer.…
Researchers modify peptides from cone snails in quest for neuropathic pain therapy Researchers in Australia have modified peptides from cone snails, which have the potential to provide relief to patients with hard-to-treat neuropathic pain.…
FDA grants priority approval for new antifungalIsavuconazonium sulfate, an antifungal developed by Astellas, has been given priority approval by the US Food and Drug Administration to treat serious infections.…
A pharmacist’s journey through the Ebola epidemicPharmacist Claire Liew is currently volunteering at an Ebola treatment centre in Sierra Leone. She explains how the disease has affected everyday life.…
Skin cancer drug fast tracked under early access to medicines schemeA drug for advanced skin cancer, pembrolizumab, has become the first medicine to be fast tracked to patients under the UK’s early access to medicines scheme.…
OTC and dietary products are the most common cause of drug-induced liver injury Drug-induced acute liver failure is uncommon, but over-the-counter products and dietary/herbal supplements are its most common causes, find researchers.…
Psychedelics not associated with mental health problems, researchers say People who have ever used psychedelic drugs are no more likely than non-users to experience mental health problems, say researchers.…
Newborn deaths cut by cleaning umbilical stump with chlorhexidine, study finds Chlorhexidine applied to the umbilical cord of newborns reduces the risk of infection of the umbilical stump by 50% and neonatal mortality by 12%, review finds.…